Otsuka Holdings Co., Ltd.: all 780 studies

Page 3 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.

• A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With SchizophreniaCompletedNCT02220712Phase 1Results posted
• Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral AripiprazoleCompletedNCT02219009Phase 2Results posted
• Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious DistressCompletedNCT02196506Phase 3Results posted
• Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With ImpulsivityCompletedNCT02194933Phase 3Results posted
• Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02160145Phase 3Results posted
• Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult VolunteersCompletedNCT02108288Phase 1Results posted
• Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02105285Phase 3Results posted
• Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02105272Phase 3Results posted
• Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS)CompletedNCT02103478Phase 1/2Results posted
• Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)CompletedNCT02091882Phase 4Results posted
• A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male SubjectsCompletedNCT02088697Phase 1Results posted
• A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck CancerCompletedNCT02085460Phase 2Results posted
• A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)CompletedNCT02069119Phase 1Results posted
• A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic DermatitisCompletedNCT02068352Phase 2Results posted
• Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute SchizophreniaCompletedNCT02054702Phase 3Results posted
• A Study of TAS-120 in Patients With Advanced Solid TumorsCompletedNCT02052778Phase 1/2Results posted
• Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive DisorderCompletedNCT02046564Phase 3Results posted
• An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euvolemic or Hypervolemic HyponatremiaTerminatedNCT02020278Phase 3Results posted
• Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode SchizophreniaCompletedNCT02013622Phase 3Results posted
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work EnvironmentCompletedNCT02013609Phase 3Results posted
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety SymptomsCompletedNCT02013531Phase 3Results posted
• Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic HyponatremiaTerminatedNCT02012959Phase 3Results posted
• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive TherapyCompletedNCT02012218Phase 3Results posted
• A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)CompletedNCT02009878Phase 1/2Results posted
• A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid LeukemiaCompletedNCT01961882Phase 2Results posted
• Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in AsiaCompletedNCT01955837Phase 3Results posted
• A Short Treatment Study of Aripiprazole in Pediatric Patients With SchizophreniaCompletedNCT01942161Phase 2/3Results posted
• A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With SchizophreniaCompletedNCT01942148Phase 3Results posted
• Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity DisorderCompletedNCT01939353Phase 2Results posted
• Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT01922258Phase 3Results posted
• Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With SchizophreniaCompletedNCT01909466Phase 1Results posted
• Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal DialysisCompletedNCT01895322Phase 2Results posted
• A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or HemodiafiltrationCompletedNCT01876381Phase 2Results posted
• A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM DepotCompletedNCT01870999Phase 1Results posted
• A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's AgitationCompletedNCT01862640Phase 3Results posted
• A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)CompletedNCT01859923Phase 2Results posted
• PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With SchizophreniaCompletedNCT01854944Phase 1Results posted
• A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal CancerCompletedNCT01801930Phase 1Results posted
• Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)CompletedNCT01799941Phase 4Results posted
• ABF Tourette's Disorder Post Marketing Surveillance StudyCompletedNCT01795105Results posted
• Pletaal SR Post Marketing Observational StudyCompletedNCT01782833Results posted
• Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease PatientsCompletedNCT01767129Phase 2Results posted
• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)CompletedNCT01752933Phase 2Results posted
• A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy SubjectCompletedNCT01737931Phase 1Results posted
• A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus TrialCompletedNCT01727726Phase 3Results posted
• Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727713Phase 3Results posted
• Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727700Phase 3Results posted
• Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I DisorderCompletedNCT01710709Phase 3Results posted
• SGI-110 in Combination With Carboplatin in Ovarian CancerCompletedNCT01696032Phase 2Results posted
• A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2)CompletedNCT01684202Phase 2Results posted
• Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With SchizophreniaCompletedNCT01683058Phase 3Results posted
• Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive DisorderCompletedNCT01670279Phase 1Results posted
• Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With SchizophreniaCompletedNCT01668797Phase 3Results posted
• Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without AuraCompletedNCT01667679Phase 3Results posted
• Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With SchizophreniaCompletedNCT01663532Phase 3Results posted
• Confirmatory Study of OPC-12759 Ophthalmic SolutionCompletedNCT01660256Phase 3Results posted
• Multicenter, Open-label, Safety and Tolerability StudyCompletedNCT01649557Phase 2Results posted
• An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With SchizophreniaCompletedNCT01646827Phase 1Results posted
• A Dose-ranging Study for SPM 962 in Parkinson's Disease PatientsCompletedNCT01634243Phase 2Results posted
• A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease PatientsCompletedNCT01631825Phase 3Results posted
• A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease PatientsCompletedNCT01631812Phase 2Results posted
• A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease PatientsCompletedNCT01628965Phase 2/3Results posted
• A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease PatientsCompletedNCT01628926Phase 3Results posted
• A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease PatientsCompletedNCT01628848Phase 2Results posted
• POCone-UBiT-IR300 Pediatric Comparison StudyCompletedNCT01623154Phase 4Results posted
• A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic DisorderCompletedNCT01617460Phase 3Results posted
• A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic DisorderCompletedNCT01617447Phase 3Results posted
• Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard ChemotherapiesCompletedNCT01607957Phase 3Results posted
• Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's DiseaseCompletedNCT01584440Phase 2Results posted
• Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I PatientsCompletedNCT01567527Phase 3Results posted
• A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs SyndromeCompletedNCT01562743Phase 2Results posted
• Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than AripiprazoleCompletedNCT01552772Phase 1Results posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleTerminatedNCT01509053Phase 3Results posted
• Exploratory Study of OPC-12759 Ophthalmic SuspensionCompletedNCT01493180Phase 2Results posted
• Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial FibrillationTerminatedNCT01483183Phase 1Results posted
• Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)CompletedNCT01475370Phase 1Results posted
• Safety Study of OPC-12759 Ophthalmic SolutionCompletedNCT01471093Phase 1Results posted
• Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular CarcinomaTerminatedNCT01465464Phase 3Results posted
• A Long-term Trial of OPC-34712 in Patients With SchizophreniaCompletedNCT01456897Phase 3Results posted
• 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT01451827Phase 2Results posted
• A Dose-finding Trial of OPC-34712 in Patients With SchizophreniaCompletedNCT01451164Phase 2/3Results posted
• Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive DisorderCompletedNCT01447576Phase 2Results posted
• A Phase I Study of OCV-501 in Acute Myeloid Leukemia PatientsCompletedNCT01440920Phase 1Results posted
• Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure PatientsCompletedNCT01439009Phase 4Results posted
• Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's TypeCompletedNCT01438060Phase 3Results posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleCompletedNCT01432444Phase 3Results posted
• Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant TuberculosisCompletedNCT01424670Phase 3Results posted
• Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT01423916Phase 1Results posted
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)CompletedNCT01418352Phase 3Results posted
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01418339Phase 3Results posted
• Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01416441Phase 3Results posted
• Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular CarcinomaCompletedNCT01406574Phase 1/2Results posted
• Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With SchizophreniaCompletedNCT01397786Phase 3Results posted
• Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute SchizophreniaCompletedNCT01396421Phase 3Results posted
• Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic CancerCompletedNCT01395017Phase 2Results posted
• Efficacy Study of OPC-34712 in Adults With Acute SchizophreniaCompletedNCT01393613Phase 3Results posted
• Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)CompletedNCT01360866Phase 3Results posted
• Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)CompletedNCT01360645Phase 3Results posted
• Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)CompletedNCT01360632Phase 3Results posted
• Phase I Study of OPB-51602 in Patients With Hematologic MalignanciesCompletedNCT01344876Phase 1Results posted

← Otsuka Holdings Co., Ltd. overview and focus areas